H6H
AMPH icon

Hightower 6M Holding’s Amphastar Pharmaceuticals AMPH Stock Holding History

Hightower 6M Holding’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$290K Sell
10,307
-5,691
-36% -$186K 0.03% 183
2022
Q2 		$557K Sell
15,998
-115
-0.7% -$4.1K 0.05% 130
2022
Q1 		$578K Buy
+16,113
New +$457K 0.04% 135

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hightower 6M Holding's AMPH Position: Q3 2022 in Review

Hightower 6M Holding reduced its Amphastar Pharmaceuticals (AMPH) stake by 36% in Q3 2022, selling an estimated $186K and leaving 10,307 shares worth $290K. The position accounts for 0.03% of the portfolio, ranked #183.

Hightower 6M Holding first reported a position in AMPH in Q1 2022 and has held it in 3 quarters since. The position peaked at $578K in Q1 2022. 207 funds tracked by Wall St. Rank hold AMPH as of Q3 2022.

  • Hightower 6M Holding held 10,307 shares of Amphastar Pharmaceuticals worth $290K as of Q3 2022.
  • Hightower 6M Holding sold 5,691 Amphastar Pharmaceuticals shares in Q3 2022, an estimated $186K.
  • Amphastar Pharmaceuticals made up 0.03% of Hightower 6M Holding's portfolio in Q3 2022, its #183 holding.
  • Hightower 6M Holding first reported a position in Amphastar Pharmaceuticals in Q1 2022 and has held it in 3 quarters since.
  • Hightower 6M Holding's Amphastar Pharmaceuticals position peaked at $578K in Q1 2022.
  • 207 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2022.

Based on Hightower 6M Holding's 13F filing for Q3 2022, filed 25 Oct 2022.